|
FDA Nod For Quidel’s HMPV Test
Leading diagnostic test solutions provider Quidel Corporation (NASDAQ:QDEL) has won the approval of the U.S. Food and Drug Administration (“FDA”) for its new virus test dubbed the “Quidel Molecular hMPV Assay”. The test is designed for the detection of human metapneumovirus (hMPV) infection. The Quidel Molecular hMPV is among the several promising upcoming assays from [...]
Leading diagnostic test solutions provider Quidel Corporation (NASDAQ:QDEL) has won the approval of the U.S. Food and Drug Administration (“FDA”) for its new virus test dubbed the “Quidel Molecular hMPV Assay”. The test is designed for the detection of human metapneumovirus (hMPV) infection. |
| ||||||
Display market data, financial news or stock quotes - Learn More
Advertise on FinancialContent's huge network - Learn More
Power your internet and wireless applications - Learn More
